OpenAlex 6,252 works 258 author topics
Works
6,252 works
-
YÖKSİS
SJR Q1
JCR Q3
OpenAlex top 1%
OpenAlex 99.9%
Graves' orbitopathy (GO) is the main extrathyroidal manifestation of Graves' disease, though severe forms are rare. Management of GO is often suboptimal, largely because available treatments do not target pathogenic mechanisms of the disease. Treatment should rely on a thorough assessment of the activity and severity…
-
YÖKSİS
SJR Q2
JCR Q4
OpenAlex top 10%
OpenAlex 98.2%
No abstract yet.
-
YÖKSİS
SJR Q2
JCR Q4
OpenAlex top 10%
OpenAlex 98.2%
No abstract yet.
-
YÖKSİS
SJR Q3
JCR Q4
OpenAlex top 10%
OpenAlex 98.2%
No abstract yet.
-
YÖKSİS
SJR Q1
JCR Q1
OpenAlex top 1%
OpenAlex 99.2%
BACKGROUND AND OBJECTIVES: Endothelial dysfunction is an early manifestation of vascular injury and contributes to the development of atherosclerotic cardiovascular disease. Recent studies have implicated hyperuricemia as a risk factor for cardiovascular disease. We hypothesized that lowering uric acid in subjects wit…
-
YÖKSİS
SJR Q2
JCR Q3
OpenAlex top 10%
OpenAlex 94.2%
No abstract yet.
-
OpenAlex top 10%
OpenAlex 97.9%
BACKGROUND: Determination of serum uric acid concentrations and role in risk of metabolic syndrome (MS) were investigated in 1877 participants in a cross-sectional population-based study including a brief follow-up. METHODS: The MS was identified by modified criteria of the Adult Treatment Panel III, and coronary hear…
-
YÖKSİS
SJR Q1
JCR Q2
OpenAlex top 10%
OpenAlex 93.7%
BACKGROUND: Mitochondria are the main production site of free oxygen radicals, which can cause organ dysfunction by oxidation of cellular macromolecules such as carbohydrates, lipids and proteins. Oxidative stress may result from either overproduction of these species or from failure of the antioxidant defence systems…
-
YÖKSİS
SJR Q1
JCR Q1
OpenAlex top 1%
OpenAlex 99.6%
BACKGROUND: Among people with diabetes, those with kidney disease have exceptionally high rates of cardiovascular (CV) morbidity and mortality and progression of their underlying kidney disease. Finerenone is a novel, nonsteroidal, selective mineralocorticoid receptor antagonist that has shown to reduce albuminuria in…
-
YÖKSİS
SJR Q1
JCR Q2
OpenAlex top 10%
OpenAlex 93.5%
OBJECTIVE: Metabolic syndrome (MetS) is a cluster of metabolic abnormalities with insulin resistance (IR) as a major component. It has been recently questioned whether MetS and its related components are associated with functional and morphological alterations of the thyroid gland. The aim of our study is to examine t…
-
YÖKSİS
SJR Q1
JCR Q3
OpenAlex top 10%
OpenAlex 93.5%
OBJECTIVE: Metabolic syndrome (MetS) is a cluster of metabolic abnormalities with insulin resistance (IR) as a major component. It has been recently questioned whether MetS and its related components are associated with functional and morphological alterations of the thyroid gland. The aim of our study is to examine t…
-
YÖKSİS
OpenAlex top 10%
OpenAlex 93.5%
OBJECTIVE: Metabolic syndrome (MetS) is a cluster of metabolic abnormalities with insulin resistance (IR) as a major component. It has been recently questioned whether MetS and its related components are associated with functional and morphological alterations of the thyroid gland. The aim of our study is to examine t…
Academicians
258 academicians
- CEVDET AYDIN 77 author topics
- ABBAS ALİ TAM 57 author topics
- MURAT FAİK ERDOĞAN 54 author topics
- MUSTAFA ŞAHİN 49 author topics
- AHMET DİRİKOÇ 48 author topics
- ŞEFİKA BURÇAK POLAT 47 author topics
- DİDEM ÖZDEMİR 37 author topics
- ECE BÖBER 32 author topics
- DİLEK TÜZÜN 31 author topics
- CEM SÜER 29 author topics
- RIFAT BİRCAN 28 author topics
- KAMİLE GÜL 27 author topics